Cargando…

Fasting Plasma C-Peptide and Micro- and Macrovascular Complications in a Large Clinic-Based Cohort of Type 1 Diabetic Patients

OBJECTIVE—A protective effect of residual β-cell function on microvascular complications of type 1 diabetes has been suggested. Our aim was to retrospectively evaluate the association of fasting plasma C-peptide values with micro- and macrovascular complications. RESEARCH DESIGN AND METHODS—We recru...

Descripción completa

Detalles Bibliográficos
Autores principales:	Panero, Francesco, Novelli, Giulia, Zucco, Chiara, Fornengo, Paolo, Perotto, Massimo, Segre, Olivia, Grassi, Giorgio, Cavallo-Perin, Paolo, Bruno, Graziella
Formato:	Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2009
Materias:	Epidemiology/Health Services Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2628697/ https://www.ncbi.nlm.nih.gov/pubmed/19017769 http://dx.doi.org/10.2337/dc08-1241

Ejemplares similares

C-Reactive Protein and 5-Year Survival in Type 2 Diabetes: The Casale Monferrato Study
por: Bruno, Graziella, et al.
Publicado: (2009)

Prevalence and incidence of microvascular and macrovascular complications over 15 years among patients with incident type 2 diabetes
por: An, Jaejin, et al.
Publicado: (2021)

Association between pre-diabetes and microvascular and macrovascular disease in newly diagnosed type 2 diabetes
por: Palladino, Raffaele, et al.
Publicado: (2020)

Cardiovascular Complications of Diabetes: From Microvascular to Macrovascular Pathways
por: Zakir, Mehreen, et al.
Publicado: (2023)

Increased QT Interval Dispersion Predicts 15-Year Cardiovascular Mortality in Type 2 Diabetic Subjects: The population-based Casale Monferrato Study
por: Giunti, Sara, et al.
Publicado: (2012)

Time to Development of Overt Diabetes and Macrovascular and Microvascular Complications Among Patients With Prediabetes: A Retrospective Cohort Study
por: Finocchio, Tyler, et al.
Publicado: (2021)

Hemoglobin A1c in combination with fasting plasma glucose trumps fasting plasma glucose alone as predictive indicators for diabetes mellitus: an ambidirectional cohort study of Thai people with impaired fasting glucose
por: Thamakaison, Sangsulee, et al.
Publicado: (2021)

Response to Comment on: Gruden et al. Severe Hypoglycemia and Cardiovascular Disease Incidence in Type 1 Diabetes: The EURODIAB Prospective Complications Study. Diabetes Care 2012;35:1598–1604
por: Gruden, Gabriella, et al.
Publicado: (2012)

Prevalence and Control of Diabetes and Impaired Fasting Glucose in New York City
por: Thorpe, Lorna E., et al.
Publicado: (2009)

Macrovascular Complications in Patients with Diabetes and Prediabetes
por: Huang, Dou, et al.
Publicado: (2017)

Associations of Cardiorespiratory Fitness and Obesity With Risks of Impaired Fasting Glucose and Type 2 Diabetes in Men
por: Lee, Duck-chul, et al.
Publicado: (2009)

Higher fasting plasma glucose is associated with striatal and hippocampal shape differences: the 2sweet project
por: Zhang, Tianqi, et al.
Publicado: (2016)

Prevalence and predictive modeling of undiagnosed diabetes and impaired fasting glucose in Taiwan: a Taiwan Biobank study
por: Chung, Ren-Hua, et al.
Publicado: (2023)

Fasting Plasma Glucose at 24–28 Weeks to Screen for Gestational Diabetes Mellitus: New evidence from China
por: Zhu, Wei-wei, et al.
Publicado: (2013)

Association of fasting plasma glucose variability with gestational diabetes mellitus: a nationwide population-based cohort study
por: Kim, Jung A, et al.
Publicado: (2020)

Fasting Versus Postload Plasma Glucose Concentration and the Risk for Future Type 2 Diabetes: Results from the Botnia Study
por: Abdul-Ghani, Muhammad A., et al.
Publicado: (2009)

Sex differences in the association of fasting and postchallenge glucose levels with grip strength among older adults: the Rancho Bernardo Study
por: Kalyani, Rita Rastogi, et al.
Publicado: (2015)

OR34-02 Fasting Pancreatic Polypeptide Predicts Incident Microvascular And Macrovascular Complications Of Type 2 Diabetes
por: Sam, Amir H, et al.
Publicado: (2023)

Type 2 Diabetes Mellitus and Macrovascular Complications
por: Shan, Peng-Fei, et al.
Publicado: (2017)

Genetics of macrovascular complications in type 2 diabetes
por: Tonyan, Ziravard N, et al.
Publicado: (2021)

Prevalence of diabetes and impaired fasting glucose in Peru: report from PERUDIAB, a national urban population-based longitudinal study
por: Seclen, Segundo N, et al.
Publicado: (2015)

Undiagnosed diabetes and impaired fasting glucose in HFE C282Y homozygotes and HFE wild-type controls in the HEIRS Study
por: Barton, James C, et al.
Publicado: (2016)

Relationship Between Risk Factors and Mortality in Type 1 Diabetic Patients in Europe: The EURODIAB Prospective Complications Study (PCS)
por: Soedamah-Muthu, Sabita S., et al.
Publicado: (2008)

Shortening of leucocyte telomere length is independently correlated with high body mass index and subcutaneous obesity (predominantly truncal), in Asian Indian women with abnormal fasting glycemia
por: Bhatt, Surya Prakash, et al.
Publicado: (2022)

To what extent do hospitalised patients receive appropriate CT and MRI scans? Results of a cross-sectional study in Southern Italy
por: Bianco, Aida, et al.
Publicado: (2018)

Macrovascular complication phenotypes in type 2 diabetic patients
por: Papa, Giuseppe, et al.
Publicado: (2013)

Microvasular and macrovascular complications in diabetes mellitus: Distinct or continuum?
por: Chawla, Aastha, et al.
Publicado: (2016)

Protective role of NRF2 in macrovascular complications of diabetes
por: Wu, Junduo, et al.
Publicado: (2020)

Cost of diabetes mellitus and related macrovascular complications in Turkiye
por: Birinci, Suayip, et al.
Publicado: (2023)

Effectiveness, treatment durability, and treatment costs of canagliflozin and glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes in the USA
por: Singhal, Mukul, et al.
Publicado: (2019)

Association Between Glucagon-Like Peptide 1 Receptor Agonist and Sodium–Glucose Cotransporter 2 Inhibitor Use and COVID-19 Outcomes
por: Kahkoska, Anna R., et al.
Publicado: (2021)

Trends in Postpartum Diabetes Screening and Subsequent Diabetes and Impaired Fasting Glucose Among Women With Histories of Gestational Diabetes Mellitus: A report from the Translating Research Into Action for Diabetes (TRIAD) Study
por: Ferrara, Assiamira, et al.
Publicado: (2009)

Clinical burden of diabetes in Italy in 2018: a look at a systemic disease from the ARNO Diabetes Observatory
por: Bonora, Enzo, et al.
Publicado: (2020)

Associations of pre-pregnancy impaired fasting glucose and body mass index among pregnant women without pre-existing diabetes with offspring being large for gestational age and preterm birth: a cohort study in China
por: Tang, Jie, et al.
Publicado: (2021)

Glucagon-like peptide 1 agonists for treatment of patients with type 2 diabetes who fail metformin monotherapy: systematic review and meta-analysis of economic evaluation studies
por: Bagepally, Bhavani Shankara, et al.
Publicado: (2020)

Effect of Glycemic Treatment and Microvascular Complications on Menopause in Women With Type 1 Diabetes in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Cohort
por: Kim, Catherine, et al.
Publicado: (2014)

Musculoskeletal Complications in Type 1 Diabetes
por: Larkin, Mary E., et al.
Publicado: (2014)

The Effect of Age and NT-proBNP on the Association of Central Obesity with 6-Years Cardiovascular Mortality of Middle-Aged and Elderly Diabetic People: The Population-Based Casale Monferrato Study
por: Bruno, Graziella, et al.
Publicado: (2014)

NT-proBNP Linking Low-Moderately Impaired Renal Function and Cardiovascular Mortality in Diabetic Patients: The Population-Based Casale Monferrato Study
por: Bruno, Graziella, et al.
Publicado: (2014)

Diabetic microvascular complications: possible targets for improved macrovascular outcomes
por: D’Elia, John A, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_6j65kb0ne57ng00kcf8f70jq3s